Image pharmaphorum Editor News Vertex wins European approval for new cystic fibrosis combin... European regulators have approved Vertex’s new cystic fibrosis (CF) combination treatment Symkevi. Digital Sponsored Intelligent HCP engagement in Europe – what do doctors want? The opportunity to engage with HCPs digitally has never been more prevalent. News Augmented reality pre-surgery tech approved by US regulator The US Food and Drug Administration (FDA) has approved a pre-surgery augmented reality imaging system that will allow doctors to see inside patients before a surgical procedure. News Grünenthal buys certain rights to AZ’s Nexium and Vimovo for... AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million. Load more results
News Vertex wins European approval for new cystic fibrosis combin... European regulators have approved Vertex’s new cystic fibrosis (CF) combination treatment Symkevi.
Digital Sponsored Intelligent HCP engagement in Europe – what do doctors want? The opportunity to engage with HCPs digitally has never been more prevalent.
News Augmented reality pre-surgery tech approved by US regulator The US Food and Drug Administration (FDA) has approved a pre-surgery augmented reality imaging system that will allow doctors to see inside patients before a surgical procedure.
News Grünenthal buys certain rights to AZ’s Nexium and Vimovo for... AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
